Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$5.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 51 most recent Form 4 transactions.
| $12.4K |
| -0.9% |
| Open the original filing on SEC.gov |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,844 | $50.71 | $93.5K | -6.8% | Open the original filing on SEC.gov |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,916 | $50.03 | $145.9K | -9.7% | Open the original filing on SEC.gov |
| Sep 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Aug 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,100 | $59.35 | $65.3K | -4.2% | Open the original filing on SEC.gov |
| Aug 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 3,900 | $58.37 | $227.6K | -13.0% | Open the original filing on SEC.gov |
| Aug 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 63 | $53.92 | $3.4K | -0.3% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,184 | $53.42 | $116.7K | -8.0% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,063 | $52.39 | $108.1K | -7.0% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 459 | $51.55 | $23.7K | -1.5% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 231 | $50.05 | $11.6K | -0.8% | Open the original filing on SEC.gov |
| Jul 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,133 | $44.74 | $50.7K | -4.3% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,599 | $43.87 | $114K | -9.0% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,268 | $42.83 | $54.3K | -4.2% | Open the original filing on SEC.gov |
| Jun 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Jun 4 | KURA | Kura Oncology, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 223 | $41.21 | $9.2K | -0.9% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 1,302 | $40.25 | $52.4K | -4.9% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 3,475 | $39.53 | $137.4K | -11.6% | Open the original filing on SEC.gov |
| May 18 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,441 | $48.06 | $117.3K | -8.9% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 2,419 | $47.39 | $114.6K | -8.1% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 140 | $45.81 | $6.4K | -0.5% | Open the original filing on SEC.gov |
| Apr 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 40,000 | $35.10 | $1.4M | -61.5% | Open the original filing on SEC.gov |
| Mar 25 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 40,000 | $2.48 | $99.2K | +160.0% | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 5,000 | $27.76 | $138.8K | -16.7% | Open the original filing on SEC.gov |
| Mar 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 5,000 | $2.48 | $12.4K | +20.0% | Open the original filing on SEC.gov |
| Mar 10 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 10,129 | — | — | — | Open the original filing on SEC.gov |
| Mar 10 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 10,129 | $30.19 | $305.8K | -28.8% | Open the original filing on SEC.gov |
| Mar 10 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 10,129 | $2.48 | $25.1K | +40.5% | Open the original filing on SEC.gov |
| Mar 9 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 29,871 | — | — | — | Open the original filing on SEC.gov |
| Mar 9 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 29,871 | $30.02 | $896.8K | -54.4% | Open the original filing on SEC.gov |
| Mar 9 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 29,871 | $2.48 | $74.1K | +119.5% | Open the original filing on SEC.gov |
| Feb 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 45,000 | $26.17 | $1.2M | -64.3% | Open the original filing on SEC.gov |
| Feb 17 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 45,000 | $2.48 | $111.6K | +180.0% | Open the original filing on SEC.gov |
| Feb 12 | ELVN | Enliven Therapeutics, Inc. | AGRANT◆ | 150,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | ELVN | Enliven Therapeutics, Inc. | AGRANT | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | KURA | Kura Oncology, Inc. | AGRANT◆ | 28,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | IOBT | IO Biotech, Inc. | AGRANT◆ | 35,144 | — | — | — | Open the original filing on SEC.gov |